The American College of Cardiology and American Heart Association reached the same conclusion in 2019.

A cardiologist in London has attracted significant media attention after reportedly selling at-home testing kits for the new coronavirus for more than $400—and racking up considerable profits.

Efforts to limit the spread of the new coronavirus have made all of us extra cautious about germs and familiar with the concept of social distancing—but that doesn’t mean all exercise has to be put on hold.

A new survey from Cardiovascular Business examines the attitudes and priorities of leaders in cardiology and other specialties, shining light on how patient care may evolve in the years ahead.

Key chemotherapy treatments are known to have a negative impact on cardiovascular health, even leading to heart failure (HF) in some patients.

The American Heart Association (AHA) has shared new recommendations for providing emergency cardiovascular care, including CPR, to patients with known or suspected COVID-19.

The Montreal Heart Institute has launched a new clinical trial aimed at improving care for patients who have been diagnosed with COVID-19.

Of COVID-19 patients who develop serious heart complications, most don’t see this problem until late in the disease’s progression. However, some are turning up with extensive heart inflammation at the outset.

Americans are dying from cardiovascular disease (CVD) caused or exacerbated by hypertension at alarmingly higher rates than in years past.

Cardiovascular care professionals must consider the concerns and views of healthcare workers, members of hospital/health system leadership and, not least, patients—whether the latter are infected with COVID-19 or not.